Global Alzheimer’s Platform Foundation® (GAP) development of a transatlantic Alzheimer’s disease clinical trial network
Background The Global Alzheimer’s Platform Foundation® (GAP) was launched in 2015 in response to the critical need to improve the delivery of Alzheimer’s disease (AD) clinical trials. Over 80 AD sites have joined GAP’s growing network (GAP‐Net). While initial efforts were focused on North America, a...
Saved in:
Published in | Alzheimer's & dementia Vol. 17; no. S9 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.12.2021
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!